Contact
searchSearch
HMP Global
Login

Psych Congress Network

Latest News, Insights, and Quizzes

Andrew Penn
Clinical Pearls
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
From Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
From Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
From Psych Congress NP Institute
Chelsie Monroe and Desiree Matthews
APP Perspectives
How Psychiatric NPs Can Broaden Their Career Horizons
03/28/2025
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute...
03/28/2025
Psych Congress NP Institute
From Psych Congress NP Institute
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
Study on MDD - stock image
News
Phase II Trial of AL001 for MDD Set to Begin Later this Year
03/24/2025
Jolynn Tumolo
Plans have been announced for a phase II clinical study of investigational lithium therapy AL001 for MDD, focusing on its unique properties and its effect on lithium delivery in the brain compared with marketed lithium salts.
Plans have been announced for a phase II clinical study of investigational lithium therapy AL001 for MDD, focusing on its unique properties and its effect on lithium delivery in the brain compared with marketed lithium salts.
Plans have been announced for a...
03/24/2025
Psych Congress Network
US FDA sign
News
FDA Seeks Clearer Labeling for Transmucosal Buprenorphine Product Dosing
03/24/2025
Jolynn Tumolo
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that...
03/24/2025
Psych Congress Network
3 medical professionals stand together talking in the hallway of a medical facility
News
Accelerated Theta-Burst Stimulation Protocol Improves Treatment-Resistant Depression
03/21/2025
Jolynn Tumolo
A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to results from a randomized clinical trial published in JAMA Psychiatry.
A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to results from a randomized clinical trial published in JAMA Psychiatry.
A novel 78-minute accelerated...
03/21/2025
Psych Congress Network
Raj K. Kalapatapu, MD, PhD
KOL Perspective
Selecting a Medication From Within a Therapeutic Class of Psychotropic Medications
03/20/2025
the right psychotropic medication can be challenging, but Raj K. Kalapatapu, MD, PhD, an Associate Professor of Psychiatry at UCSF, offers a practical framework to simplify the process.
the right psychotropic medication can be challenging, but Raj K. Kalapatapu, MD, PhD, an Associate Professor of Psychiatry at UCSF, offers a practical framework to simplify the process.
the right psychotropic...
03/20/2025
Psych Congress Network
Thomas L. Schwartz, MD
Q&As
A Psychiatrist’s Role in Tackling Sleep-Wake Disorders
03/18/2025
Thomas L. Schwartz, MD, explores medicine’s evolving understanding of insomnia, narcolepsy, and idiopathic hypersomnia from a neuroscientific perspective.
Thomas L. Schwartz, MD, explores medicine’s evolving understanding of insomnia, narcolepsy, and idiopathic hypersomnia from a neuroscientific perspective.
Thomas L. Schwartz, MD, explores...
03/18/2025
Psych Congress Network
an older man wearing glasses rubs his face in stress tired depression treatment resistant depression
News
Genetic Predispositions to Insomnia, Neuroticism, Linked With Higher Risk for Treatment-Resistant Depression
03/18/2025
Jolynn Tumolo
A genetic predisposition to traits including neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistant depression (TRD) in a cohort study published in JAMA Psychiatry.
A genetic predisposition to traits including neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistant depression (TRD) in a cohort study published in JAMA Psychiatry.
A genetic predisposition to...
03/18/2025
Psych Congress Network

Latest Expert Insights

Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
Raj K. Kalapatapu, MD, PhD
KOL Perspective
Selecting a Medication From Within a Therapeutic Class of Psychotropic Medications
03/20/2025
the right psychotropic medication can be challenging, but Raj K. Kalapatapu, MD, PhD, an Associate Professor of Psychiatry at UCSF, offers a practical framework to simplify the process.
the right psychotropic medication can be challenging, but Raj K. Kalapatapu, MD, PhD, an Associate Professor of Psychiatry at UCSF, offers a practical framework to simplify the process.
the right psychotropic...
03/20/2025
Psych Congress Network
Thomas L. Schwartz, MD
Q&As
A Psychiatrist’s Role in Tackling Sleep-Wake Disorders
03/18/2025
Thomas L. Schwartz, MD, explores medicine’s evolving understanding of insomnia, narcolepsy, and idiopathic hypersomnia from a neuroscientific perspective.
Thomas L. Schwartz, MD, explores medicine’s evolving understanding of insomnia, narcolepsy, and idiopathic hypersomnia from a neuroscientific perspective.
Thomas L. Schwartz, MD, explores...
03/18/2025
Psych Congress Network
Brittany Albright
Q&As
Evaluating Anhedonia With Patient-Centered Strategies
03/11/2025
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and...
03/11/2025
Psych Congress Network
Dr Brittany Albright
Q&As
Exploring Anhedonia in Psychiatric Care
03/04/2025
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress...
03/04/2025
Psych Congress Network
Examining Novel Treatment Methods in Schizophrenia
Videos
Examining Novel Treatment Methods in Schizophrenia
02/25/2025
Christoph U. Correll, MD
In this discussion, Christoph Correll, MD, professor of psychiatry at the Zucker School of Medicine, delves into the groundbreaking FDA approval of xanomeline/tropsium chloride, a novel treatment for schizophrenia that moves beyond...
In this discussion, Christoph Correll, MD, professor of psychiatry at the Zucker School of Medicine, delves into the groundbreaking FDA approval of xanomeline/tropsium chloride, a novel treatment for schizophrenia that moves beyond...
In this discussion, Christoph...
02/25/2025
Psych Congress Network
Steven Chan, MD, MBA, FAPA, FAMIA
Videos
Barriers and Misconceptions to Digital Therapeutic Integration
02/14/2025
Steven Chan, MD, MBA
In this video, Steven Chan, MD, MBA, FAPA, FAMIA, Psych Congress Steering Committee, explains some of the barriers that virtual clinicians should anticipate when weighing digital therapeutic options for major depressive disorder (MDD)...
In this video, Steven Chan, MD, MBA, FAPA, FAMIA, Psych Congress Steering Committee, explains some of the barriers that virtual clinicians should anticipate when weighing digital therapeutic options for major depressive disorder (MDD)...
In this video, Steven Chan, MD,...
02/14/2025
Psych Congress Network
Steven Chan, MD, MBA, FAPA, FAMIA
Videos
Tapping into Neuroplasticity Through Digital Therapeutics for MDD
02/10/2025
Steven Chan, MD, MBA
Steven Chan, MD, MBA, FAPA, FAMIA, explains how telehealth providers can explore and adopt digital therapeutics for their virtual practices.
Steven Chan, MD, MBA, FAPA, FAMIA, explains how telehealth providers can explore and adopt digital therapeutics for their virtual practices.
Steven Chan, MD, MBA, FAPA,...
02/10/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D....
02/05/2025
Psych Congress Network
Brooke Kempf, PMHNP-BC
Videos
Improving Patient Outcomes With Early Initiation of LAIs
02/05/2025
Brooke Kempf, MSN, PMHNP-BC
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting...
02/05/2025
Psych Congress Network

From the Newsrooms

Andrew Penn
Clinical Pearls
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
Chelsie Monroe and Desiree Matthews
APP Perspectives
How Psychiatric NPs Can Broaden Their Career Horizons
03/28/2025
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute...
03/28/2025
Psych Congress NP Institute
Dr Steven Chan
Expert Insights Quiz
Choosing the Right Digital Therapeutic for MDD Treatment
03/18/2025
Steven Chan, MD, MBA; Meagan Thistle
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress...
03/18/2025
Psych Congress Network
Brittany Albright
Q&As
Evaluating Anhedonia With Patient-Centered Strategies
03/11/2025
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and A, Brittany Albright, MD, MPH, Psych Congress Elevate faculty member and founder of Sweetgrass Psychiatry, discusses 2 of her favorite anhedonia treatment strategies.
In part 2 of this Q and...
03/11/2025
Psych Congress Network
Dr Brittany Albright
Q&As
Exploring Anhedonia in Psychiatric Care
03/04/2025
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress Elevate faculty member Dr Brittany Albright discusses the challenging symptoms of anhedonia and its significant impact on patients' quality of life and clinical outcomes.
In this Q&A, Psych Congress...
03/04/2025
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
Analysis Estimates 0.45% Schizophrenia Prevalence in United States
12/10/2024
Jolynn Tumolo
More patients with schizophrenia are covered by Medicare and Medicaid compared with commercial payers in the United States, according to results from a 2022 claims analysis presented in a poster at Psych Congress. “Among the Medicaid...
More patients with schizophrenia are covered by Medicare and Medicaid compared with commercial payers in the United States, according to results from a 2022 claims analysis presented in a poster at Psych Congress. “Among the Medicaid...
More patients with schizophrenia...
12/10/2024
Psych Congress Network
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Videos
Understanding Antipsychotic-Induced Movement Disorders
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia, as well as the different management approaches for each.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia, as well as the different management approaches for each.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress Network
woman schizophrenia depression smart phone
News
Cognitive Symptoms May Be as Burdensome as Psychosis for Patients Living With Schizophrenia
12/04/2024
Brionna Mendoza
Patients living with schizophrenia discussed cognitive symptoms of the disease less often than psychotic symptoms, cognitive and other negative symptoms were “perceived” as “equally burdensome” as the positive symptoms of the disease due to...
Patients living with schizophrenia discussed cognitive symptoms of the disease less often than psychotic symptoms, cognitive and other negative symptoms were “perceived” as “equally burdensome” as the positive symptoms of the disease due to...
Patients living with...
12/04/2024
Psych Congress Network

Quizzes

Dr Steven Chan
Expert Insights Quiz
Choosing the Right Digital Therapeutic for MDD Treatment
03/18/2025
Steven Chan, MD, MBA; Meagan Thistle
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress Steering Committee Member Steven Chan, MD, MBA, which of the following are important considerations when selecting and implementing digital therapeutics for the treatment of MDD?
According to Psych Congress...
03/18/2025
Psych Congress Network
Did OUD diagnoses increase or decrease in VHA patients?
Quiz
Did OUD diagnoses increase or decrease in VHA patients?
02/25/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/25/2025
Psych Congress Network
Charles Raison headshot
Expert Insights Quiz
First-Line Treatment Options for Insomnia
02/21/2025
Charles L. Raison, MD
True or False: According to Psych Congress Steering Committee Member, Charles Raison, MD, the first-line treatment for primary insomnia is medication, including benzodiazepines.
True or False: According to Psych Congress Steering Committee Member, Charles Raison, MD, the first-line treatment for primary insomnia is medication, including benzodiazepines.
True or False: According to...
02/21/2025
Psych Congress Network
Quiz
Quiz
Cariprazine FDA-Approved Indications
02/21/2025
Meagan Thistle
Is cariprazine FDA-approved as an adjunctive treatment for major depressive disorder (MDD)? What is another FDA-approved indication for this drug? Take the quiz to test your psychopharmacology knowledge!
Is cariprazine FDA-approved as an adjunctive treatment for major depressive disorder (MDD)? What is another FDA-approved indication for this drug? Take the quiz to test your psychopharmacology knowledge!
Is cariprazine FDA-approved as...
02/21/2025
Psych Congress Network
How many US Psychiatric Hospitals Provided Medications for OUD?
Quiz
How many US psychiatric hospitals provided medications for OUD?
02/06/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/06/2025
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
DSM-5 Quiz: Mood Symptoms in Schizophrenia
02/03/2025
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
02/03/2025
Psych Congress Network
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How can clinicians help patients with ADHD transition from adolescence to adulthood?
Quiz
How can clinicians help patients with ADHD transition from adolescence to adulthood?
01/22/2025
Do you remember this interview with Dr Wilens?
Do you remember this interview with Dr Wilens?
Do you remember this interview...
01/22/2025
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Quiz
Conditions That Mimic ADHD in Pediatric Patients
01/21/2025
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
01/21/2025
Psych Congress Network
Quiz
Quiz
What percentage of people experience hypomanic symptoms during an MDD episode?
01/15/2025
Meagan Thistle
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study...
01/15/2025
Psych Congress Network

Recent FDA Updates

FDA building
News
FDA Approves Once-Monthly Lecanemab-irmb Dosing for Early Alzheimer Disease
01/28/2025
Meagan Thistle
The FDA has approved a supplemental biologics license application for lecanemab-irmb (Leqembi, Eisai Co., Ltd.; Biogen Inc.), an intravenous treatment (IV) for early Alzheimer disease (AD).
The FDA has approved a supplemental biologics license application for lecanemab-irmb (Leqembi, Eisai Co., Ltd.; Biogen Inc.), an intravenous treatment (IV) for early Alzheimer disease (AD).
The FDA has approved a...
01/28/2025
Psych Congress Network
US FDA sign
News
Posdinemab Granted Fast Track Designation by the FDA for Early Alzheimer Disease
01/10/2025
Brionna Mendoza
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated...
01/10/2025
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Evi Arthur
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
FDA approval featuring craig chepke
News
FDA Approves First Schizophrenia Treatment in Over 3 Decades
09/27/2024
Meagan Thistle
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug...
09/27/2024
Psych Congress Network
fda building sign
News
FDA Rejection of MDMA-Assisted Therapy for PTSD Divides Psychedelic Stakeholders
08/16/2024
Brionna Mendoza
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug...
08/16/2024
Psych Congress Network

Live Meetings

Psych Congress Family & Friends Podcast

Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D....
02/05/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
A New Beginning, and a Fond Farewell
01/06/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig...
01/06/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Welcome to Psych Congress Family & Friends Hosted by Rakesh Jain and Craig Chepke
01/06/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry and psychopharmacology podcast aimed at enhancing your clinical practice in an approachable and heartfelt way, hosted by Rakesh Jain, MD, MPH, and Craig Chepke, MD, DFAPA. Subscribe now!
Introducing our new psychiatry...
01/06/2025
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use